Specialty
Aesthetics Cardiology Cataract & Refractive Dermatology General Ophthalmology Glaucoma Neuro-Ophthalmology Oculoplastics Optometry Retina Women's Health View All Courses
Course Type
Evaluation Supplement Multimedia Webinar Podcast In-Person Multi-part Collection
Search
Login

Neurotrophic Keratitis: A “Rare Disease” Yet Common Problem

By: Francis S. Mah, MD (Chair); Marjan Farid, MD; Sumitra Khandelwal, MD; Elizabeth Yeu, MD

This course has expired. You can still review the content but course credit is no longer available.

Supplement Credits: 1

This continuing medical education (CME) activity captures content from a live symposium.

Based on a live satellite symposium held during the American Society for Cataract and Refractive Surgeons Annual Meeting, this supplement summarizes the presentations on the stages of neurotrophic keratitis and the available treatments.

This certified CME activity is designed for ophthalmologists.

Expiration Date: Wednesday, November 30, 2022
Release Date: October 1, 2021

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Identify the stages of neurotrophic keratitis
  • Recognize how to differentiate neurotrophic keratitis from similar diseases
  • Describe the mechanisms of action of newer treatments and when they should be introduced into treatment regimens for neurotrophic keratitis, including the stepwise approach
  • Explain the relationships between disease characteristics, drug therapies, treatment frequency, visual, and anatomic outcomes

Accreditation and Designation Statement

This educational activity is provided by Evolve Medical Education LLC (Evolve).

Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
Evolve designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participation Method

In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS

Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+

Faculty and Disclosures

Francis S. Mah, MD (Chair)

Director of Corneal and External Disease
Co-Director of Refractive Surgery
Scripps Clinic

La Jolla, CA
 

Marjan Farid, MD

Director of Cornea, Cataract, and Refractive Surgery
Vice Chair of Ophthalmic Faculty
Clinical Professor of Ophthalmology
Gavin Herbert Eye Institute
University of California, Irvine
Irvine, California

Sumitra Khandelwal, MD

Associate Professor
Medical Director – Lions Eye Bank of Texas
Cornea, Cataract, and Refractive Surgery
Baylor College of Medicine
Houston, TX

Elizabeth Yeu, MD

Virginia Eye Consultants
Medical Director, CVP Mid-Atlantic
Cornea, Cataract, External Disease, and Refractive Surgery
Assistant Professor
Department of Ophthalmology
Eastern Virginia Medical School
Norfolk, VA

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Francis S. Mah, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Allergan, Bausch + Lomb, Eyenovia, Glaukos, iView, Johnson & Johnson Vision, Nevakar, Novartis, Ocular Science, and RxSight. 

Marjan Farid, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Bausch + Lomb, BioTissue, Carl Zeiss Meditec, CorneaGen, Dompé, Tarsus, Orasis, Johnson & Johnson Vision, Kala Pharmaceuticals, Novartis, and Sun Pharmaceutical Industries.

Sumitra Khandelwal, MD, has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Alcon Vision, Bausch + Lomb, Carl Zeiss Meditec, Dompé, Novartis, and Ocular Therapeutix.

Elizabeth Yeu, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Allergan, Avedro, Bausch + Lomb, BioTissue, Beaver Visitec, BlephEx, Bruder, Carl Zeiss Meditec, CorneaGen, Dompé, Expert Opinion, EyePoint Pharmaceuticals, Guidepoint, Johnson & Johnson Vision, Kala Pharmaceuticals, Lensar, Merck, Mynosys, Novartis, Ocular Science, Ocular Therapeutix, Ocusoft, Omeros, Oyster Point Pharma, Science Based Health, Shire, Sight Sciences, Sun Pharmaceutical Industries, Surface, Thea, Tarsus, TopCon, TearLab, Visus Therapeutics. Grant/Research Support: Alcon Vision, BioTissue, Ocular Science, TopCon, and TearLab. Stock/Shareholder: BlephEx, CorneaGen, Melt, Ocular Science, Oyster Point Pharma, and Tarsus. 

The Evolve staff and planners have no financial relationships with commercial interests. Michelle Dalton, writer, and Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Cataract & Refractive Surgery Today, MillennialEYE, or Dompé.

Begin Course